JW (Cayman) Therapeutics Co Ltd banner

JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Watchlist Manager
JW (Cayman) Therapeutics Co Ltd Logo
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Watchlist
Price: 1.88 HKD 1.62% Market Closed
Market Cap: HK$783m

JW (Cayman) Therapeutics Co Ltd
Investor Relations

JW (Cayman) Therapeutics Co. Ltd. operates as a clinical stage cell therapy platform company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-11-03. The firm is focuses on developing cell therapies for the China market to transform the treatment of cancer for Chinese patients. Through its subsidiary, it has built an integrated platform focused on developing, manufacturing and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its main product candidate, relmacabtagene autoleucel (relma-cel), is an autologous anti-CD19 CAR-T therapy for relapsed or refractory (r/r) B-cell lymphoma. The firm mainly conducts its businesses in the China market.

Show more
Loading
2126
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Yiping Li M.D.
Co-Founder & Interim Chairman
No Bio Available
Mr. Min Liu
CEO & Executive Director
No Bio Available
Cao Xiaoping Ph.D.
Senior Vice President of Tech Operations
No Bio Available
Dr. Shaun Paul Cordoba Ph.D.
Senior VP & Chief Scientific Officer
No Bio Available
Mr. Raymond J. Hage Jr.
Senior Vice President of Corporate Development
No Bio Available
Mr. Mark J. Gilbert M.D.
Senior Advisor & Acting Chief Medical Officer
No Bio Available
Mr. Qiang Ma
Senior VP & Chief Commercial Officer
No Bio Available
Ms. Yun Qin
Senior Vice President of Clinical Sciences & Medical Services
No Bio Available
Dr. Su Yang
Senior Vice President Of Clinical Research & PMO
No Bio Available
Ms. Ka Man Ng A.C.I.S., A.C.S.
Company Secretary
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
4F, Building 42, No. 225 Meisheng Road, Pilot Free Trade Zone
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett